United Therapeutics Corporation (UTHR) valuation · P/E 19, rev $3.18B
United Therapeutics Corporation (UTHR) P/E 19, rev $3.18B.
| Metric | Value |
|---|---|
| P/E | 19 |
| Market cap | $23.41B |
| Revenue | $3.18B |
| P/S | 7.4 |
| P/B | 3.9 |
UTHR valuation FAQ
What is UTHR's P/E ratio?
United Therapeutics Corporation (UTHR) trailing P/E is 19 on the latest cached fundamentals snapshot.
What is UTHR's market cap?
United Therapeutics Corporation (UTHR) market cap is $23.41B on the latest cached fundamentals snapshot.
What is UTHR's latest revenue?
Latest cached United Therapeutics Corporation (UTHR) revenue was $3.18B. Statements: https://lician.com/financials/uthr
What is UTHR's price-to-sales ratio?
United Therapeutics Corporation (UTHR) price-to-sales (P/S) is 7.4, cached market cap $23.41B divided by revenue $3.18B.
What is UTHR's price-to-book ratio?
United Therapeutics Corporation (UTHR) price-to-book (P/B) is 3.9 on the latest cached fundamentals snapshot.
How many UTHR valuation scalars are listed on this page?
This page lists 5 cached valuation scalars for United Therapeutics Corporation (UTHR): P/E, Market cap, Revenue, P/S, and P/B.
Where is UTHR valuation listed?
Cached valuation multiples for United Therapeutics Corporation (UTHR) are listed at https://lician.com/valuation/uthr.
Not investment advice. Cached rows, not a live tape.